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ABSTRACT
Present methods for DNA isolation of
stool have various limitations such as the
amount of stool used, the requirement of
lavage fluids or the use of fresh stool. In this
paper, a new method is described for the
isolation of human nucleic acids from stool,
which is independent from the moment of
collection. Fecal samples as dry as possible
were collected from 75 patients; two grams
of stool were mixed with a lysis buffer con-
taining phenol. DNA yields of crude stool
were variable and ranged from 9–1686
mg/g of feces. With dot blots in 9 of the 75
cases, the human DNA was identified and
ranged from 0.06%–46%. In the remaining
66 cases, human genomic DNA was detect-
ed by nested PCR, using human K-ras gene
amplification as an example. Amplification
products were confirmed for human K-ras
with the exonuclease-amplification coupled
capture technique (EXACCT). In conclu-
sion, the developed DNA isolation method
can be used for the study of large numbers
of stool samples, is independent of the age
or method of stool collection and is suitable
for large-scale screening studies.
INTRODUCTION
Secondary prevention of colorectal
cancer by means of screening stool for
tumor cells is a recent and promising
field of research. (16,17) Several studies
have been reported on the detection of
K-ras (7,16,17) and other mutations
(5,21) in exfoliated cells of stool
(12,16,17) or colonic lavage fluids
(18,21). The methods reported for DNA
extraction are quite varied (9,17), and
specific restrictions are frequently re-
quired, such as the fresh collection of
stool, the use of colonic effluents,
colonic wash, direct isolation or storage
at -70°C (5,7,11,13,15). Fresh collec-
tion is used in most studies and may be
feasible in an experimental setting, but
is not a useful characteristic for popula-
tion-based screening. A similar reason-
ing also applies to the use of colonic ef-
fluent samples after colonic wash. Stool
collection by the patient at home with-
out any prerequisites would be the best
way for population-based screening. Up
to now, DNA isolated from normal stool
could only be amplified with variable
success (5,7,11), which precluded the
use of normal stool for DNA analysis. 
Normally, 80% of the water content
from fecal material is reabsorbed in the
large bowel (6). Thus, a certain state of
fecal dehydration may occur, which re-
sults in inactivation of degradative en-
zymes. Conversely, adding water to
stool results in a rapid breakdown of
nucleic acids. In fact, soft rocks in
Egypt’s desert along the Nile are actu-
ally dehydrated dromedary droppings,
probably present since the last rainfall
(21). Based on the concept of relative
dehydration of stool, the purpose of this
study was to develop a simple method
for DNA isolation, which has little or
no specific requirements at the time of
stool collection and so can be used for
further specific DNA analysis in popu-
lation-based studies.
MATERIALS AND METHODS
DNA Isolation of Fecal Samples
Fecal samples from 75 patients vis-
iting the outpatient clinics of the de-
partment of surgery at Maastricht Uni-
versity Hospital were collected as dry
as possible and kept in a closed tube at
room temperature for 24–48 h before
DNA isolation was initiated. Two
grams of stool were resuspended in a
15 mL tube containing a lysis buffer
with two liquid phases at 4°C. One con-
sisted of 4 mL PBS (115 mM NaCl, 8
mM KCL, 1.6 mM KH2PO4 pH 7.4)
with 0.9% SDS and 18 mM EDTA, and
the other consisted of 4 mL phenol/
chloroform/isoamyl alcohol (IAA, 25:
24:1) buffered at pH 8. Approximately
1 g of glass beads with a diameter of 1
mm (Emergo, Landsmeer) was added
for mechanical resuspension of the
stool. The beads were pretreated
overnight with 0.25 M HCl and washed
in distilled water until the pH was neu-
tral before use.
After being vigorously stirred, the
mixture was heated to 65°C for 10 min
and rapidly frozen in a dry ice/ethanol
bath or stored at -70°C until further han-
dling. The frozen samples were cen-
trifuged at 286´ g for 45 min at room
temperature, during which thawing oc-
cured. Subsequently, the water phase
was transferred to a clean tube and used
for a second extraction with 4 mL phe-
nol/chloroform/IAA (25:24:1). After
another centrifugation at 286´ g for 20
min at room temperature, 10% cetyltri-
methylammonium bromide (CTAB),
0.7 M NaCl was added to the water
phase to a final concentration of 2.3%
CTAB, 0.16 M NaCl. Subsequently, two
extractions with 4 mL chloroform/IAA
(24:1) were performed. DNA was pre-
cipitated by the addition of 1/10 vol 3 M
sodium acetate pH 5.2 and 2.5 vol of
ethanol and placed for 20 min at -20°C.
For further analysis, the DNA was dis-
solved in 200–500 mL sterile water, and
50 mg/mL RNAse were added. DNA
concentrations of the samples were de-
termined by A260/280 measurements.
Dot Blot Analysis
Dot blotting was performed as de-
scribed by Maniatis et al. (12). From
each of the fecal DNA samples, 10 and
20 mL volumes were dissolved in 500
mL 6´ standard saline citrate. As a ref-
erence, a serial dilution of human pla-
cental DNA that contained 1 mg, 100
ng, 10 ng, 1 ng, 100 pg, 10 pg and 1 pg,
respectively per dot were blotted and
hybridized simultaneously with the fe-
cal samples. Hybridization was per-
formed with human placental DNA as
probe, labeled with -32P dCTP using
random priming labeling. The presence
of human DNA was detected by count-
Short Technical Reports
286 BioTechniques Vol. 28, No. 2 (2000)
DNA Yield n positive
mg/g na (%)
1–100 24 5 (21)
100–200 16 2 (13)
200–400 13 1 (8)
400–800 15 1 (7)
800–686 7 0 (0)
an = number of samples
Table 1. Distribution of Total DNA Yield (mg/g
Feces) in Relation to Samples Positive with Dot
Blot for Human DNA
ing the hybridized radioactivity per dot
in a Winspectral 1414 (Wallac, Turku,
Finland) liquid scintillation counter. In
each fecal sample, the amount of hu-
man DNA was estimated by the mean
of duplicate samples and compared to
the reference signals of human placen-
tal DNA. The mean plus three times the
standard deviation of the background
signal was arbitrarily chosen as the cut-
off value for positivity.
Amplification of Human DNA
in a PCR
Determination of the PCR. As an
example for the amplification of a sin-
gle copy, human gene primers specific
for the human K-ras gene were used.
Amplification and gel electrophoresis
were performed as previously de-
scribed (19). The reaction mixture con-
tained primer 1 (sense, 5¢-TTTTTATT-
ATAAGGCCTGCTG-3¢) and primer 2
(antisense, 5¢-TCAGAGAAACCTTT-
ATCTGTATCAAAGAATGG-3¢), both
4 ng/mL, resulting in amplification of a
204 bp fragment. As template in the
amplification reaction, 20 ng per 20 mL
PCR volume of human H716 cell line
DNA were spiked in serially diluted fe-
cal DNA. The final concentration of fe-
cal DNA in the PCR mixture (as a frac-
tion of undiluted fecal DNA) was 1/5,
1/50, 1/500, 1/5000 and 1/50 000. The
dilution 1/5 was obtained by adding 4
mL of undiluted DNA to 20 mL PCR to-
tal volume, which allowed identifica-
tion of the dilution of stool DNA that
permitted DNA amplification.
Identification of human DNA by
nested PCR. The primers 1 and 2 (out-
side primers) are located just outside
the first exon. For nested PCR, the
same conditions were used with primer
3 (sense, 5¢-ATGACTGAATATAAAC-
TTGTGGTAG-3¢) and primer 4 (anti-
sense, 5¢-CCTCTATTGTTGGATCAT-
ATTCG-3¢) for 30 cycles. These nested
primers resulted in amplification of a
112 bp fragment containing the whole




pled capture technique (EXACCT) im-
proves detection of the PCR product (8).
Statistical Analysis
The distribution of total fecal DNA
and outcome of the dot blots were eval-
uated with the chi-square test. P values
<0.05 were considered significant.
RESULTS
DNA Extraction From Stool
To keep the relative dehydrated
state, fecal samples as dry as possible
were collected  and stored in tubes with
closed lids at room temperature up to
48 h. Before opening the tubes, the
samples were cooled to 4°C and han-
dled rapidly to avoid potential enzy-
matic degradation of nucleic acids. Af-
ter mixing the fecal samples with lysis
buffer and dissolving the isolated
nucleic acids in distilled water, small
samples were run on agarose gels to vi-
sually judge the DNA quality. The ex-
tracted water phase usually showed
high molecular weight DNA and a
smear with variable intensity. The treat-
ment of the samples with RNAse A re-
moved the smear component and de-
monstrated its RNA nature. Apparently,
the dry storage of stool and rapid han-
dling in the first steps resulted in isola-
tion of both DNA and RNA.
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No. of
Cycles 1/5 1/50 1/500 1/5000 1/50 000 Total
After spiking 40 1 20 33 18 3 75
Wthout spiking 40 0 2 10 15 11 38
Without spiking 70 6 22 38 9 - 75
Table 2. Dilutions of Fecal DNA that Give the First Positive Results on Agarose Gel for Variation in
Cell Cycle with and without Spiking of Control Human DNA
The amount of total DNA isolated for
the stool samples ranged from 9–1686
mg DNA per gram of stool (mean ± SD =
319 ± 365 mg DNA per gram of stool).
Detection of Human DNA by Dot
Blotting
To quantify the amount of human
DNA, dot blots of fecal DNA were hy-
bridized with a human placental DNA
probe. DNA quantities of 1–5 ng human
reference DNA per dot were easily de-
tectable, but lower amounts of human
DNA usually gave no signal above the
background threshold values (Figure 1).
Control samples of the bacterial DNA
did not hybridize with the human ge-
nomic DNA probe. Nine of the 75 fecal
samples gave a distinct hybridization
signal. In the majority of the cases, hu-
man genomic DNA could not be
demonstrated with dot blot hybridiza-
tion. By comparing the signals of the fe-
cal samples with the reference values,
an approximation was obtained for the
amount of human DNA in each sample.
The amount of human DNA as a frac-
tion of total DNA ranged in the positive
samples from 0.06%–46% (mean 11%).
Table 1 shows the distribution of total
amounts of isolated DNA and the out-
come of the dot blot hybridization. Re-
markably, a tendency towards an inverse
relation was found between the amount
of total DNA and positivity on dot blots.
Seven of the nine cases with a detectable
amount of human DNA on dot blot were
obtained from samples with a DNA
yield below the mean content (P=0.28).
In fact, DNA yields of those seven sam-
ples were even below 160 mg DNA per
gram of stool (P=0.10). The dot blot re-
sults did not change when 10´ less DNA
were analyzed.
Detection of Human DNA by PCR
Because in most stool samples the
human DNA could not be demonstrated
with dot blot analyses, the presence of
human DNA in all stool samples was
further examined with PCR using
primers specific for the human K-ras
gene. The initial PCR with undiluted
fecal DNA did not result in a visible
band on agarose gels. To examine the
presence of possible inhibitors in the
PCR, serially diluted fecal DNA was
spiked with a known amount of human
control DNA as the template for ampli-
fication. For the different dilutions, the
distribution of the number of spiked
samples with the first positive signal is
shown in Table 2. All samples showed
a visible band for K-ras, although the
dilutions in which a band was visible
varied considerably. The final concen-
tration of total fecal DNA in the spiked
samples that allowed for first-time am-
plification of the human K-ras gene
ranged from 0.018–13.200 ng/mL
(mean ± SD = 2.2 ± 3.0 ng/mL). These
results suggests the presence of in-
hibitor(s) in isolated fecal DNA.
To avoid the effect of inhibitors, fecal
DNA dilutions for the unspiked PCR
were based on the results of the spiking
experiment with the first positive signal.
In only 38 of 75 cases, a faint amplifica-
tion product was found after 40 cycles of
PCR. However, when nested PCR was
performed, amplification of human ge-
nomic DNA could be demonstrated in
all cases (Table 2). To confirm that the
amplification products consisted of the
human K-ras gene, the EXACCT proce-
dure was performed. Clear spectropho-
tometer readouts proved the presence of
human DNA in all samples.
Expressing the PCR in ratios of the
amount of DNA maximally working in
a PCR (up to 2 mg/100 mL) revealed
that in 27 samples, the maximum DNA
concentration was present where a PCR
product was detected. In 41 samples, a
10´ dilution was necessary, while  a
100´ dilution was necessary in the re-
maining seven samples before a PCR
product of the correct size was visible.
We expected a positive PCR product
within 40 cycles of amplification for
K-ras in the nine cases that were posi-
tive with dot blotting and had a large
amount of human DNA. However, this
was so in only six of the nine cases.
DISCUSSION
In this study, we describe a new
method to isolate DNA from stool,
which has several advantages. It is
unique to the method that crude stool is
used and no specials pretreatment of pa-
tients or samples is necessary. Stool
specimens can easily be collected by the
patient because, other than dry storage,
no specific conditions are required  up
to 48 h after samples are collected. Our
method may be a further step in the de-
velopment of a protocol to evaluate
large numbers of samples. Furthermore,
the amplification of single-copy human
genes from isolated fecal DNA was
possible in all cases, which indicates
that the human genomic DNA was not
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Figure 1. The mean and standard deviation of 9 blots are shown for the calibration points contain-
ing different amounts of human placental DNA. Note that amounts of DNA lower than 1 ng are not
detectable, that is, the signal is equal to background (A.U.= arbitrary units).
degraded, at least in part. The amount of
stool used for isolation was 2 g. This
factor is 2–10´ greater than used in
most other studies (5,12,15), and so re-
duces the chance for a sampling error.
The fraction of human DNA in the
samples isolated from stool is low.  Hu-
man DNA could be detected with dot
blotting in only 12% of the cases. A
large variation in the amount of human
DNA was observed and ranged from
0.06%–46%.
With PCR, 40 cycles amplification
of undiluted total fecal DNA did not
lead to a visible product. When undilut-
ed samples were spiked with a known
amount of human genomic DNA, in
only one case was a visible band
demonstrated. This statistic is in agree-
ment with other studies (9,18). Howev-
er, the human K-ras gene could be
demonstrated in all diluted spiked sam-
ples, which emphasizes the presence of
at least one inhibitor in fecal material
that can be diluted from the samples. In
general, the samples with high DNA
yields needed higher dilutions in the
PCR before a positive signal could be
demonstrated. This may indicate that an
excess of bacterial DNA inhibits PCR.
The same theory may apply for dot blot
hybridization. However, changing the
DNA concentration with dot blotting
did not improve the outcome. Remark-
ably, for samples with a similar fecal
DNA concentration, a large variation
was noticed in the dilution with the first
positive signal in PCR. This result and
the fact that three of nine cases positive
for dot blotting did not show a visible
PCR product after 40 rounds of PCR
proves that another inhibitor may be
present apart from bacterial DNA.
Müller and Roth tried to separate the in-
hibitors by using an absorption matrix
with carbohydrates and colestipolhy-
drochlorid, respectively (3,16).
In our procedure, the effect of the in-
hibitors is diminished by dilution. A
drawback of dilutions is that the initial
concentration of human DNA in the
PCR mixture may be low for the detec-
tion of single-copy genes after 40 cy-
cles of amplification. This may explain
the fact that only 41% of the cases were
positive with a signal of variable inten-
sity after the first round of PCR. The
amount is similar to that  described by
Villa et al. (45%) (19) for one round of
PCR. To increase the sensitivity for
mutation detection in DNA extracted
from stool, nested PCR has been per-
formed before (2). Interestingly, in all
stool samples irrespective of variation
in consistency (1), human DNA could
be demonstrated after a second round
of amplification. Apparently, more cy-
cles were necessary to clearly obtain
visible bands after gel electrophoresis.
Hybridization of the amplification
products in the EXACCT procedure
confirmed that the human K-ras gene
was amplified in the consecutive ampli-
fication reactions. It is noteworthy that
the EXACCT procedure has a higher
specificity than in Southern blotting,
for example, in which two probes with
adequate hybridization are required be-
fore a signal is obtained.
The use of phenol in the first step of
the isolation procedure has several ad-
vantages. The liquid phase at room tem-
perature is used for mixing of the more
compact stool. In addition, the polar na-
ture will contribute further separation of
lipophilic and hydrophilic components
of the dissolved fractions. Moreover, the
cooling in a dry ice-ethanol bath will re-
sult in freezing of the phenol with nee-
dle formation (4). This may have a local
effect on membranes in the stool-buffer
mixture. At this  time, the mixture can
be stored until further use. Freezing of
the dry stool before using the isolation
mixture leads to some degradation that
is made visible with a more intense
smear on agarose gels.
Before using stool for large-scale
sceening of malignant diseases, several
factors must still be studied and should
focus mainly on selective isolation of
human DNA. In a method described by
Lapidus, cross sections from stool were
taken with the intention of a representa-
tive sampling of tumor cells possibly
attaching in a line on one side of the
stool lump (10). Other factors are cool-
ing the stool below its gel freezing
point, with subsequent washing of the
epithelial cells from the surface. (14) In
methods described by Vogelstein and
Kinzler, a stool lysis buffer is used to
lyse eukaryotic cells for the subsequent
separation of the bacteria by centrifuga-
tion (17,23). In contrast, our method
does not use a strategy of cell enrich-
ment or separation of bacteria.
The limitations of our DNA isola-
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tion procedure from stool are a double
phenol/chloroform extraction step and
a dilution step that is frequently re-
quired for PCR, which leads to a de-
crease in the amount of tumor DNA
that possibly drops under the detection
limit. During our procedure, the heat-
ing step can possibly be avoided, while
in stool with weak consistency, glass
beads can be omitted. This step may
lead to a relative increase of human
DNA because the amount of lysed bac-
teria is likely to decrease. Up to now,
patient compliance to our method was
extremely high. Moreover, the DNA
isolation method requires no specific
sampling buffer. Both characteristics
are suitable for large-scale screening.
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